Peptica-C Dosage & Drug Information

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing Brand Resources

Concise Prescribing Info

Contents

Dried Al hydroxide 300 mg, Mg trisilicate 200 mg, simethicone 20 mg

Indications/Uses

Symptomatic relief of gastric hyperacidity, dyspepsia due to hyperacidity & heartburn.

Click to view Peptica-C detailed prescribing information

Dosage/Direction for Use

1-2 tab.

Click to view Peptica-C detailed prescribing information

Overdosage

View Peptica-C overdosage for action to be taken in the event of an overdose.

Administration

Should be taken on an empty stomach: Take 1-2 hrs after meals. Chew & swallow.

Contraindications

Hypersensitivity.

Click to view Peptica-C detailed prescribing information

Special Precautions

May mask internal bleeding symptoms secondary to NSAIDs. Avoid concomitant use w/ tetracycline, quinolones, propranolol, atenolol, captopril, ranitidine, famotidine & aspirin. Al may cause nausea, vomiting & constipation; risk of osteomalacia in patients w/ low phosphate diet. Hypermagnesaemia may occur w/ impaired renal function. Mg hydroxide & other Mg salts may cause CNS depression w/ renal insufficiency; may cause diarrhea potentially leading to dehydration.

Click to view Peptica-C detailed prescribing information

Use In Pregnancy & Lactation

Click to view Peptica-C detailed prescribing information

Adverse Reactions

Nausea, vomiting & constipation, intestinal obstruction; osteomalacia. Diarrhoea; hypermagnesaemia; CNS depression.

Click to view Peptica-C detailed prescribing information

Drug Interactions

Reduced absorption of alendronate, digoxin w/ Al or Mg hydroxide, Mg trisilicate. Concurrent use w/ calcitriol may lead to hypermagnesemia (monitor for Mg intoxication if cannot be avoided). Decreased renal elimination of ephedrine (monitor for potential ephedrine toxicity). May increase AUC of glipizide or glyburide w/ Mg hydroxide (monitor for signs of hypoglycemia if concomitant use cannot be avoided). Increased level of mefenamic acid & tolfenamic acid (monitor for potential NSAID toxicity).

Click to view Peptica-C detailed prescribing information

Caution For Usage

For caution against possible variation of physical aspect of medicine... Click to view Peptica-C detailed prescribing information

Storage

View Peptica-C storage conditions for details to ensure optimal shelf-life.

Description

View Peptica-C description for details of the chemical structure and excipients (inactive components).

Action

View Peptica-C mechanism of action for pharmacodynamics and pharmacokinetics details.

MIMS Class

Antacids, Antireflux Agents & Antiulcerants

ATC Classification

A02AF - Antacids with antiflatulents ; Used in the treatment of acid-related disorders.

Regulatory Classification

POM

Presentation/Packing

Form

Peptica-C chewable tab

Packing/Price

4 × 5 × 10's

Peptica-C

Manufacturer:

Geno

Distributor:

Nebula

Marketer:

Mascots